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Abstract A general strategy for the ampli¢ed expression in
Escherichia coli of membrane transport and receptor proteins
from other bacteria is described. As an illustration we report the
cloning of the putative K-ketoglutarate membrane transport
gene from the genome of Helicobacter pylori, overexpression
of the protein tagged with RGS(His)6 at the C-terminus, and
its puri¢cation in mg quantities. The retention of structural and
functional integrity was veri¢ed by circular dichroism spectros-
copy and reconstitution of transport activity. This strategy for
overexpression and puri¢cation is extended to additional mem-
brane proteins from H. pylori and from other bacteria.
' 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
The lipid cell membrane of bacteria is inherently imperme-
able to nutrients required for metabolism. Uptake of nutrients
(and secretion of wastes) therefore depends on the presence of
transport proteins, which operate by a variety of mechanisms;
examples are facilitated di¡usion, adenosine triphosphate
(ATP)-dependent primary active transport, sugar-Hþ second-
ary active transport and phosphotransferase [1]. In addition
the bacterial membrane contains proteins that sense environ-
mental conditions and, through the ‘two-component’ sensor/
kinase regulator (TCS) system, enable an appropriate re-
sponse of the cells [2]. In most cases the low abundance of
these membrane proteins and their hydrophobic nature make
them di⁄cult to isolate in amounts required for elucidation of
their three-dimensional (3D) structure and molecular mecha-
nism.
In this article a strategy is described that enables the puri-
¢cation of one protein, which is readily adapted for the puri-
¢cation of other membrane proteins in amounts required for
structural studies. Some of these are homologous to transport
proteins found in numerous organisms from cyanobacteria,
eubacteria, protozoan parasites, fungi, plants and mammals
including man [3] ; the convenience of structure^activity stud-
ies in bacteria then illuminates the molecular mechanism of
transporters in numerous organisms. Others are unique to
bacteria and critical for growth of pathogenic organisms dur-
ing infection; the availability of the puri¢ed active protein
may then be useful for discovery of novel antibacterials.
Only one example can be illustrated here, the K-ketogluta-
rate transport protein of Helicobacter pylori. Tomb et al. [4]
determined the complete genome sequence of the H. pylori
strain 26695, later compared with that of the pathogenic
strain J99 [5]. One of the genes found was jhp0334. This
was thought to encode an K-ketoglutarate membrane trans-
port protein, because its predicted amino acid sequence
aligned with 40^44% identity to the known ‘KgtP’ protein
from Escherichia coli [3,6], homologues of which occur in
Campylobacter jejuni, Salmonella typhimurium, Pseudomonas
putida, Salmonella typhi and Brucella suis, and are members
of the major facilitator superfamily of transport proteins [7].
The jhp0334 gene product is predicted to be of Mr 48 865.6
Da, comprised of 437 amino acids, the hydropathic pro¢le of
which suggests it is an integral membrane protein possibly
arranged in 12 transmembrane K-helices.
2. Materials and methods
Most of the materials and methods used in this work are described
in [8,9]. Only the most relevant detail is included here. Genomic DNA
from H. pylori strains J99 and 26695 was kindly provided by Profes-
sor D.E. Berg (St. Louis, MO, USA), from C. jejuni and Neisseria
meningitidis by Dr M.C.J. Maiden (Oxford, UK) and from Brucella
abortus by Professor R.C. Essenberg (Ohio, USA). n-Dodecyl-L-D-
maltoside (DDM) was from Melford Labs, Ipswich, Su¡olk, UK
and nickel nitrilo-triacetic acid (Ni-NTA) was from Qiagen, Ltd.,
Dorking, Surrey, UK.
E. coli strains XL1-blue Stratagene1 (recA1, endAI, gyrA96, thi-I,
hsdR17, supE44, relA1, lac [FPproAB lacIq ZvM15, Tn10 (TetR)]) and
BL21 Novagen1 (F3 ompT hsdSB(r3B m
3
B ) gal dcm (DE3)) were used
as hosts for transformation work. E. coli strain BL21(DE3) was also
used for small- and large-scale isolation of plasmids, and for over-
expression and puri¢cation of transport proteins.
Maintenance and growth of these E. coli strains was achieved by
culturing the bacteria on Luria broth (LB) [9] liquid medium, or plates
containing 1.5% agar, or minimal salts medium [9] containing 20 mM
glycerol. Carbenicillin (100 ug/ml) was used throughout all stages of
growth to maintain plasmid integrity.
For small-scale investigation of protein expression, 50-ml cultures
in 250-ml £asks at 37‡C were used. Total membranes were prepared
from sphaeroplasts by the water lysis method [9]. Inner membrane
vesicles were prepared from 500-ml cultures in 2-l ba¥ed conical
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£asks or from 25-l fermenter cultures. After harvesting the chilled (0^
4‡C) cells were disrupted by explosive decompression using a French
pressure cell. The inner and outer cell membranes were separated by
sucrose density centrifugation, followed by washing in bu¡er to re-
move sucrose and ethylenediamine tetraacetic acid (EDTA) [9].
For both small-scale and inner membrane production of E. coli
strains, growth at 37‡C was allowed to continue until the cell density
reached an A680 of approximately 0.6 when the expression of the
cloned gene was induced by the addition of isopropyl-L-D-thiogalac-
topyranoside (IPTG) to a ¢nal concentration of 0.5 mM. Growth was
continued for 3^4 h following the induction of the tac promoter, thus
producing optimal yields of protein.
2.1. Recombinant DNA procedures
The plasmid constructs used in this project were pTTQ18 [10] (Fig.
1) and pNorAH6 [11]. The jhp0334 gene from H. pylori J99 was iso-
lated by polymerase chain reaction (PCR) ampli¢cation and cloned
into the vector pTTQ18 to form pTTQ18KgtPRGSH6 (Fig. 1 and see
text). Primers were synthesised by MWG-Biotech Ltd (Milton
Keynes, UK). DNA was resuspended in sterile Milli-Q H2O at a
concentration of 5 pmol/Wl. The primers were stored at 320‡C. For-
ward primer was 5P-GCGATGAATTCGCATATGAACCCCCAGA-
TTCAACCCGCCACTAA-3P (44-mer); reverse primer was 5P-GC-
AGCCACGACCGCCTGCAGCCTCCAAATAGGTTTTTTTAGG-
GAAT-3P (46-mer). ‘Touchdown’ PCR [12] was used as it simpli¢es
the complicated process of determining optimal annealing tempera-
tures. The size of the ampli¢ed product(s) was determined by agarose
gel electrophoresis to con¢rm that the major product was as expected.
The DNA was cleaned by phenol/chloroform extraction and ethanol
precipitation.
2.2. Puri¢cation of protein
Ni-NTA a⁄nity chromatography was used to purify the membrane
proteins, which had been genetically modi¢ed with RGS(His)6 at their
C-terminus. The method is based on the a⁄nity of Ni-NTA resin for
proteins and peptides that contain six consecutive histidine residues
(hexahistidine a⁄nity tag) at either their N- or C-terminus [13,14].
The puri¢cation method was based on that of Racher et al. [15].
The inner membrane containing the overexpressed transport protein
was solubilised as follows. Membranes (5 mg/ml) in 5-ml volumes
were resuspended in 50 mM potassium phosphate bu¡er pH 8.0,
10% glycerol and 2 mM L-mercaptoethanol. DDM was added drop-
wise to give a ¢nal concentration of 1.5% w/v and the mixture stirred
for 30 min at 0‡C. Solubilised protein was recovered from the super-
natant after centrifugation at 100 000Ug for 1 h at 4‡C.
Ni-NTA agarose (stored in 30% ethanol) was washed with at least
three, 5-fold volumes of Milli-Q H2O and twice with wash bu¡er 1
consisting of 50 mM potassium phosphate bu¡er pH 8.0, 10% glyc-
erol, 10 mM imidazole pH 8.0, 0.05% w/v DDM, 2 mM L-mercapto-
ethanol and 300 mM NaCl. The solubilised membrane protein was
mixed with the Ni-NTA resin for 45 min to 1 h at 4‡C and loaded into
a mini-disposable polystyrene column (Pierce Biotechnology). Un-
bound material was recovered for analysis and non-His6-tagged pro-
tein was removed by washing the Ni-NTA agarose with 30 vol per ml
of resin with wash bu¡er 1. This was followed by a further wash with
25 vol per ml Ni-NTA agarose with wash bu¡er 2 containing 50 mM
potassium phosphate bu¡er pH 8.0 (KPi), 10% glycerol, 30 mM imi-
dazole pH 8.0, 0.05% w/v DDM, 2 mM L-mercaptoethanol and 300
mM NaCl.
Bound protein was eluted with ¢ve times 1-ml aliquots of 50 mM
potassium phosphate bu¡er pH 8.0, 10% glycerol, 200 mM imidazole
pH 8.0, 0.05% w/v DDM, 2 mM L-mercaptoethanol and 300 mM
NaCl (elution bu¡er).
2.3. Characterisation of the protein
Transport assays using intact bacteria were carried out as described
in [9,16]. Reconstitution of puri¢ed KgtP protein into preformed ex-
truded liposomes [9,17,18] prepared from E. coli lipids (Avanti Polar
Lipids Inc., Alabaster, AL, USA) was accomplished by the rapid
detergent dilution method. Liposomes were destabilised by titration
with aliquots of 13.6% (w/v) octyl-L-D-glucoside (OG) monitoring
light scattering at 540 nm. The puri¢ed protein was added to give a
¢nal lipid to protein ratio of 100:1 (w/w) and mixing was continued
for 15 min at 4‡C. The detergent was removed by the rapid dilution
technique where the protein:lipid:detergent mixture (2 ml) was diluted
to 130 ml with 50 mM KPi pH 7.6, 1 mM dithiothreitol (DTT), 20
mM K-ketoglutarate, which takes the OG below its critical micelle
concentration (CMC). The solution was then separated into two
Ti45 tubes and centrifuged at 100 000Ug for 1 h at 4‡C. The super-
natant was removed and the pellet of proteoliposomes resuspended in
maximum 1 ml (total volume) 50 mM KPi pH 7.6, 1 mM DTT, 20
mM K-ketoglutarate. Counter£ow assays employing added [14C]K-ke-
toglutarate were conducted as described [9,17].
When membrane histidine protein kinases associated with TCS sys-
tems were assayed using membrane preparations or puri¢ed proteins,
autophosphorylation of the proteins was measured directly using
[Q-33P]ATP or [Q-32P]ATP [19].
Circular dichroism (CD) measurements [20,21] on puri¢ed protein
or reconstituted proteoliposomes were made as described [9,17].
3. Results
3.1. Introduction of the gene encoding a putative transport
protein into the plasmid pTTQ18 vector
In order to clone the 1.3-kb jhp0334 gene into the pTTQ18
vector (Fig. 1), the plasmid pNorAH6 (pTTQ18 containing
the gene norAH6 [11]) was isolated from E. coli strain BLR
and digested with the restriction endonucleases EcoRI and
PstI to yield two DNA fragments of 4.59 and 1.2 kb, respec-
tively. The larger fragment of 4.59 kb (pTTQ18 with the
RGSH6-coding DNA sequence) was isolated from an agarose
gel.
The gene putatively encoding an K-ketoglutarate transport
protein was ampli¢ed from the H. pylori genomic DNA, using
mutagenic oligonucleotides (Section 2). They were designed to
introduce an EcoRI site at the 5P end and a PstI site at the 3P
end to promote subsequent ligation with the 4.59-kb pTTQ18/
RGSH6 fragment. The PCR product was isolated from an
agarose gel and then digested with EcoRI and PstI.
Ligation reactions were performed using the EcoRI^PstI-
digested gene and pTTQ18/RGSH6 fragments at various vec-
tor:insert molar ratios. After the ligated product was trans-
formed into E. coli XL1-blue, recombinant clones were se-
lected on LB plates containing carbenicillin. Plasmid DNA
was prepared from carbenicillin-resistant colonies and sub-
jected to restriction analysis with HindIII, NcoI uniquely cut-
ting restriction enzymes and automated DNA sequencing of
the 5P end to con¢rm the correct size of the plasmid and the
presence of the gene [17]. The size and DNA sequence of the
insert in the new plasmid (Fig. 1) were con¢rmed. The plas-
mid was then transformed into E. coli strain BL21(DE3) for
expression studies.
This procedure can be applied to any gene that does not
include EcoRI or PstI restriction sites. If these sites are
present in the coding region then EcoRI and PstI can still
be introduced as £anking sites and partial digestion used to
obtain a fragment uncut at the internal site(s). Alternatively,
as in the case of regB (prrB), which contains an internal
EcoRI site, a two-step cloning procedure was adopted, fol-
lowed by sequencing of the full ¢nal insert [19]. Also, other
£anking restriction sites can be chosen compatible with the
multi-cloning site in pTTQ18 [10].
3.2. Expression and activity of the cloned histidine-tagged
transport protein in E. coli
Transport proteins are readily assayed using radioisotope-
labelled substrate [16]. E. coli BL21(DE3) (pTTQ18Kgt-
PRGSH6) was grown on LB plus 20 mM glycerol in the
presence or absence of 0.5 mM IPTG, the cells were harvested
and washed and transport assays were performed.
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The IPTG-induced cells exhibited a prolonged uptake of
labelled K-ketoglutarate, which was absent from the unin-
duced bacteria (Fig. 2, inset). This was not due to K-ketoglu-
tarate transport activity of the host cells as no activity was
observed in the IPTG-induced BLR(DE3) host strain without
the plasmid [17] (not shown). Thus, the protein encoded by
the H. pylori gene on the plasmid was con¢rmed to be an
K-ketoglutarate transporter.
In the case of cloned TCS membrane receptor proteins their
ATP-dependent autophosphorylation activity can similarly be
checked in membrane preparations from IPTG-induced cells
and compared with activities from uninduced cells [19].
3.3. Detection of expressed histidine-tagged transport protein in
E. coli membrane preparations
E. coli BL21(DE3) cells harbouring each plasmid were cul-
tured in Luria^Bertani (LB) broth plus glycerol and expres-
sion trials performed with concentrations of IPTG of 0.0^1.0
mM [17]. 0.5 mM IPTG is su⁄cient for maximal expression of
the putative KgtP(His)6 protein.
After preparing membrane samples [9], sodium dodecyl sul-
phate^polyacrylamide gel electrophoresis (SDS^PAGE) anal-
ysis and staining with Coomassie brilliant blue (Fig. 2), an
Fig. 1. Cloning strategy for membrane proteins using plasmid pTTQ18 [10].
Fig. 2. a: Putative identi¢cation of the expressed KgtP(His)6 mem-
brane protein. Membranes were prepared from E. coli BL21
(pTTQ18kgtPRGSH6) grown in the presence (induced) or absence
(uninduced) of 0.5 mM IPTG (see Section 2). The proteins were
separated by SDS^PAGE and stained with Coomassie blue. The ar-
row indicates the position of the protein putatively identi¢ed as the
product of the H. pylori kgtp gene, which was con¢rmed by West-
ern blotting (Fig. 3). b: Con¢rmation of activity of the H. pylori
KgtPRGS(His)6 protein expressed in E. coli. E. coli BL21
(pTTQ18kgtPRGSH6) was grown in the presence (induced) or ab-
sence (uninduced) of 0.5 mM IPTG, harvested and washed (Section
2 and [9]). The transport of [14C-K]ketoglutarate was then measured
into each for 2 min in triplicate.
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IPTG-inducible protein is observed migrating at approxi-
mately 35 kDa. It is typical for membrane transport proteins
to migrate at 65^75% of their true molecular weight, possibly
as a result of their hydrophobicity, high binding of SDS or the
retention of secondary structure accelerating passage through
the gel mixture [9]. The predicted molecular weight of
KgtP(His)6 is 50 245.3 Da, so the migrating band would be
expected at 32^37 kDa. Scanning densitometry analysis
showed that the induced protein is expressed at 20%, indicat-
ing that overexpression has occurred, whereas the protein at
the same position in the uninduced sample is expressed at 3%
of inner membrane protein. Its identity was further con¢rmed
by Western blotting (see below).
The induced protein migrating at 35 kDa appeared in the
inner membrane sample and was absent from the outer mem-
brane sample [17], consistent with the location expected of a
transport protein.
3.4. Solubilisation and puri¢cation of histidine-tagged transport
protein
This initial puri¢cation using Ni-chelate a⁄nity chromatog-
raphy to exploit the C-terminal His-tag (Section 2) shows a
protein migrating at 35 kDa in the eluted fractions following
staining with Coomassie brilliant blue (Fig. 3), similar to the
IPTG-inducible protein migrating at this Mr in the SDS^
PAGE gel of all the membrane proteins (Fig. 2).
In order to reinforce identi¢cation of the 35-kDa protein as
KgtP(His)6 the gels were subjected to Western blot analysis
using an antibody to the C-terminal RGS(His)6-tag. Fig. 3
shows that the puri¢ed 35-kDa protein reacted with the anti-
body, con¢rming that the protein migrating at this position is
KgtP(His)6. N-terminal sequencing (MNSH MNPQIQ, the
¢rst four amino acids are from the LacZK peptide) of the
puri¢ed protein further con¢rmed its identi¢cation and its
integrity. Some minor contaminants (hardly visible on silver
staining) of lower Mr were positive with the antibody (Fig. 3),
suggesting that some breakdown of the puri¢ed protein may
have occurred.
Thus, the uncertainty of the identity of the protein resulting
from the anomalous migration on SDS^PAGE gels is over-
come by the combined detection of the predicted N-terminal
sequence and Western blot analysis for the C-terminal
RGS(His)6-tag, con¢rming that the protein migrating at
about 35 kDa is the one desired and has not been degraded
during isolation.
The conditions for solubilisation and puri¢cation, i.e.
DDM concentration for solubilisation and imidazole concen-
tration for washes and elution, vary depending on the char-
acteristics of each of the transport proteins. However, the
generic conditions described here have proved feasible and
provided an initial index of yield and purity.
3.5. Retention of structure and activity is con¢rmed by CD
spectroscopy and activity assays of reconstituted protein
CD spectroscopy is a useful technique for the detection of
Fig. 3. a: Puri¢cation (and identi¢cation) of the H. pylori
KgtPRGS(His)6 protein. Membrane preparations were solubilised in
1.5% DDM and centrifuged (Section 2). Samples of the original
preparation (‘Membrane’, with an arrow indicating the
KgtPRGS(His)6 protein), the soluble (‘Solubilised’) and insoluble
(‘Pellet’) material were examined by SDS^PAGE (Coomassie
stained). A sample of the material that failed to adhere to Ni-NTA
agarose (‘Flowthrough’) and the Ni-NTA-bound protein subse-
quently eluted by 200 mM imidazole (‘Eluted protein’) were pro-
cessed in the same gel. b: Con¢rmation of the identity of the
KgtPRGS(His)6 protein. The puri¢ed protein from a was blotted
and tested for reactivity with an anti-RGSH6 antibody by Western
blotting (Section 2).
Fig. 4. a: The KgtPRGS(His)6 protein has predominantly K-helix secondary structure. The CD spectrum of the KgtPRGS(His)6 protein was
determined in 10 mm KPi, pH 8, after reconstitution into liposomes of E. coli lipid (see Section 2). b: The KgtPRGS(His)6 protein is function-
al after puri¢cation. The puri¢ed protein was reconstituted into liposomes of E. coli lipid and a counter£ow transport assay performed for 10
min (see Section 2 and [9]) in duplicate for both proteoliposomes and liposomes.
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secondary structure within proteins, although the quantitation
of the proportions of di¡erent structural elements is severely
limited for membrane proteins [20,21]. The CD spectrum ob-
tained for the puri¢ed reconstituted KgtP(His)6 protein (Fig.
4) reveals a predominantly K-helix content, con¢rming reten-
tion of the secondary structure during puri¢cation of the pro-
tein. Furthermore, the puri¢ed reconstituted protein catalysed
K-ketoglutarate counter£ow (Fig. 4) into liposomes [9].
3.6. Wider application of the strategy for ampli¢ed expression
and puri¢cation
The same strategy, with minor modi¢cations in growth and
puri¢cation conditions, has been used for overexpression of
other membrane proteins from H. pylori (e.g. [22]), C. jejuni,
N. meningitidis, B. abortus, Staphylococcus aureus, Bacillus
subtilis, Rhodobacter sphaeroides, and Streptomyces coelicolor
(Table 1). Out of 39 attempts, 36 have so far been successful
for ampli¢cation of expression, i.e. the induced cloned protein
comprised at least 15% of the inner membrane preparations of
the E. coli host strain, and in every case (so far 16) where the
RGS(His)6-tag was added at the C-terminus the protein has
been puri¢ed successfully by Ni-NTA chromatography. In
one case, the nupC gene of E. coli, addition of an
RGS(His)6-tag could not be accomplished; this is thought
to be symptomatic of the C-terminus of this protein being
exported to the periplasm. In some cases where a parallel
construct with the (His)6-tag at the N-terminus, instead of
the C-terminus, was made, the level of expression was sub-
stantially reduced.
Growth conditions should be optimised in 1^25-l cultures of
E. coli host strains, testing both minimal and complex media
at temperatures between 25 and 37‡C to maximise expression
of each protein [9]. The concentration of IPTG required is
tested between 0.1 and 1.0 mM, and the period of growth
before induction varied to obtain as high a cell density as
possible commensurate with optimal protein expression
(growth is often diminished, or abolished, after induction).
Similarly, the period of exposure to IPTG (2^24 h) is inves-
tigated in order to promote maximum expression. In many
cases a 25-l fermenter can conveniently be used without com-
promising expression, but for some proteins the level of ex-
pression is always higher in batch cultures of 500^800 ml in
2-l ba¥ed £asks. Further examination of the parameters regu-
lating growth and protein production in these conditions may
enhance our understanding of expression.
4. Conclusions
The prime purpose of this study was to consolidate a ge-
neric procedure for obtaining su⁄cient quantities of unde-
natured transport and receptor protein(s) from a variety of
microorganisms, including pathogens, for future structural
studies. This has been achieved for nine organisms, both
Gram-positive and Gram-negative, and for 19 proteins (Table
1). The general strategy for cloning genes encoding membrane
proteins into plasmid pTTQ18, heterologous expression in
E. coli, and addition of an RGS(His)6-tag for puri¢cation
using DDM [9] cf. [22^27] is shown to be successful. It is
possible to proceed from identi¢cation of a gene encoding a
membrane protein in a bacterial genome to the production of
mg of puri¢ed protein in a few weeks, and the application of
higher throughput methods for cloning and puri¢cation will
hopefully reduce the time required. The yield and purity of
protein may well be increased by further optimisation of con-
ditions, especially for detergent extraction of protein from the
membrane. The yields are easily enough for trials to form
two-dimensional (2D) ordered arrays for electron crystallog-
raphy [28,29] and su⁄cient to start 3D crystallisation trials
for X-ray crystallography (Rutherford, Shibayama, Suzuki,
Byrne, and Iwata, unpublished) and for NMR studies [30].
In addition, the puri¢ed protein can be examined by a va-
riety of biophysical techniques ^ mass spectrometry for precise
Mr and sequence determination [31,32], FTIR, £uorimetry,
calorimetry and EPR that elucidate the structure^activity re-
lationship, especially when performed in conjunction with di-
rected mutagenesis and genetic recombination.
In recent landmark papers the 3D structures of the lactose
and K-glycerophosphate transport proteins of E. coli have
been determined by X-ray crystallography [33,34]. Future elu-
cidation of the structures of transport proteins from H. pylori,
C. jejuni, S. aureus, N. meningitidis, and other pathogens may
uncover means of preventing or treating bacterial infections.
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